Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive
Latest Information Update: 22 Sep 2023
At a glance
- Drugs NWRD-08 (Primary)
- Indications Human papillomavirus infections; Squamous intraepithelial lesions of the cervix
- Focus First in man; Therapeutic Use
- Sponsors Newish Technology (Beijing)
Most Recent Events
- 24 Jul 2023 According to a Newish Technology media release, 7 subjects have been enrolled in this IIT clinical study.
- 22 Jul 2023 According to a Newish Technology media release, the company has submitted IND application to CDE this year and has received clinical trial acceptance notice.
- 22 Jun 2023 New trial record